A campaign aiming to empower and equip rosacea patients to discuss the true burden of their disease with a dermatologist called Face Up To Rosacea has launched.
A study conducted by A Lallas et al., published in the Journal of the American Academy of Dermatology has found there to be an 8% risk for second primary melanoma within five years.
Members of the British Association of Cosmetic Nurses (BACN) have voted unanimously to update its Code of Conduct on the training of beauty therapists.
Global pharmaceutical company Galderma’s liquid formulation of botulinum toxin type A has achieved positive results for the treatment of glabellar lines in a phase 2 clinical trial.
The British Skin Foundation, a charity dedicated to raising funds for skin disease research, has conducted a survey amongst 245 dermatologists indicating that 87% believe that there is a lack of access to psychological support for those suffering with skin conditions in the UK.
A pilot study of 18 male patients has demonstrated an increase in hair density and thickness following botulinum toxin treatment.
The new Art Filler Lips Soft was launched by aesthetic company FILLMED Laboratories at the London Cabaret Club on October 9 at its Aesthetics French Kiss Conference.
Key opinion leader for Venus Concept UK Ms Magdalena Atta-Motte will present a pilot study on the Tribella treatment by Venus Versa at the at International Conference on Dermatology & Cosmetology (ICDC) in Kuala Lumpur on November 26-27.
On September 12-15, more than 250 delegates from 35 countries attend the first ever Alma Academy meeting hosted at the Sheraton Rhodes resort in Greece.
From August 29 to September 1, 1,250 delegates from across 79 countries and five continents attended the 5-Continent-Congress in Barcelona.